References
- Booth N. H., McDonald L. E. Farmacologia e terapeutica veterinaria, C. Beretta. E. M. SI., Rome 1991
- Bradbury M. The concept of a blood-brain barrier. John Wiley, Chichester 1979
- Drayer B. P., Rosenbaum A. E. Metrizamide brain penetrance. Acta Radiol. Suppl. 1977; 355: 280
- Elkin C. M., Levan A. M., Leeds N. E. Tolerance of iohexol, iopamidol and metrizamide in lumbar myelography. Surg. Neurol. 1986; 26: 542
- Fiirgard M., Madsen H. H. T., Svare U., Eriksen F. B., Skiødt T., Zeeberg I. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording. Acta Radiol. 1995; 36: 77
- Harrish P. P., Di Stefano V. Decreased cerebrospinal fluid production by intravenous sodium diatrizoate. Invest. Radiol. 1984; 19: 318
- Kerber C. W., Sovak M., Ranganathan R. S., Heilman C. B. Iotrol, a new myelographic agent. I. Radiography, CT, CSF clearance, and brain penetration. AJRN 1983; 4: 317
- Kieffer S. A., Binet E. F., Davis D. O. Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study. Invest. Radiol. Suppl. 1985; 20: 522
- La Noce A., Bertani F., Lorusso V., Luzzani F., Tirone P., de Haën C. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. Eur. J. Radiol. 1994; 18: S43, Suppl. 1
- La Noce A., Danieli A., Bertani F., Tirone P., de Haën C. Conditioned taste aversion in rats following intrathecal administration of contrast media. Acta Radiol 1996; 37: 116
- Moschini L., Manara O., Bonaldi G., Cassinari R., Quilici N., Belloni G. Iopamidol and metrizamide in cervical myelography. Side effects, EEG, and CSF changes. AJNR 1982; 4: 848
- Oldendorf W. H., Davson H. Brain extracellular space and the sink action of the cerebrospinal fluid. Arch. Neurol. 1967; 17: 196
- Sage M. R., Wilcox J. Brain parenchyma penetration by intrathecal nonionic iopamidol. AJRN 1983; 4: 1181
- Sage M. R., Wilcox J., Evill C. A., Benness G. T. Brain parenchyma penetration by intrathecal ionic and nonionic contrast media. AJRN 1982; 3: 481
- Sheng K. L., Moss A. A., Riegelman S. Saturation kinetics of iodipamide. Invest. Radiol. 1977; 12: 175
- Sovak M., Deutsch J. A., Ranganathan R. Evaluation of intrathecal contrast media by aversion conditioning in rats. Invest. Radiol. 1982; 17: 101
- Sovak M., Ranganathan R., Johnson M. Spectral analysis of lapine EEG. Neurotoxicologic evaluation of new nonionic contrast media. Invest. Radiol. 1980; 15: 452
- Wood A. K. W., Kundel H. L., McGrath J. T., Wortman J. A. Computed tomography, magnetic resonance imaging, and pathologic observations of the effects of intrathecal metrizamide and iohexol on the canine central nervous system. Invest. Radiol. 1987; 22: 672